• SENSEX 76,718.56
    148.21 (+0.19%)
  • BANKNIFTY 57,172.00
    -237.60 (--0.41%)
  • Power Fin.Corpn.
    351.60 486.45(%)
  • Netweb Technol.
    5,347.65 5,810.00(%)
  • Antelopus Selan
    1,035.95 951.45(%)
  • IFCI
    101.60 99.45(%)
  • HDFC Bank
    712.75 1,020.35(%)
  • Godrej Consumer
    859.50 891.10(%)
  • Max Healthcare
    988.00 903.50(%)
  • Milky Mist Dairy
    268.75 255.10(%)
  • Solar Industries
    21,569.40 20,760.15(%)
  • Elgi Equipments
    629.30 643.30(%)
  • Energy InfrTrust
    74.25 102.00(%)
  • Ather Energy
    1,630.00 481.25(%)
  • Bharat Dynamics
    1,266.45 1,655.25(%)
  • Jyoti CNC Auto.
    999.00 1,055.00(%)
  • Welspun Corp
    2,675.00 2,593.15(%)
  • Divi's Lab.
    9,277.55 9,296.00(%)
  • Anant Raj
    634.60 744.10(%)
  • Coal India
    428.40 490.90(%)
  • RBL Bank
    409.00 397.95(%)
  • Multi Comm. Exc.
    3,180.35 1,496.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hikal Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Kalyani
  • BSE Code : 4401.0
  • ISIN : INE475B01022
200.60 2 (1.04%)
  • As on 03 Sep 2026 (EOD)

  • Today’s Low

    197.01

  • Today’s High

    202.99

  • Open

    198.88

  • Perv Close

    198.54

  • 52W Low

    146.25

  • 52W High

    282.70

Key Indicators

  • P/E(TTM)

    58.11

  • Mar.Cap (₹Cr.)

    2,473.41

  • Div & Yield %

    0.30

  • Book Value(₹)

    97.24

  • Debt-Equity Ratio

    1.04

  • AGM Date

    02-Sep-2026

  • EPS

    3.46

  • P/E Ratio

    58.11

Financials Ratios

  • Debt-Equity Ratio

    0.67

  • Mar.Cap (₹Cr.)

    2,473.41

  • RONW (%)

    6.00

  • ROCE (%)

    7.51

Score Board

  • Equity (₹ in Cr.)

    24.66

  • BV (₹)

    97.20

  • Sales( ₹ in Cr.)

    1,712.60

  • NP (in Cr.)

    27.30

  • NP Var(%)

    -70.0

  • Div%

    30.0

  • CPS (₹)

    15.50

  • EPS (₹)

    2.20

  • Traded Value (₹ in Lakhs)

    2,478.96

  • 52 Week High

    282.70

  • 52 Week Low

    146.25

  • Price BSE

    201.0

  • Price NSE

    201.00

  • Market Capital( in Cr.)

    2,478.96

  • P/C Ratio

    13.00

  • P/E Ratio

    90.80

  • Price Vs.BV

    2.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,712.60 1,859.80 1,784.60 2,023.03 1,942.72 1,720.44
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,712.60 1,859.80 1,784.60 2,023.03 1,942.72 1,720.44
Other Income 12.30 5.00 2.50 5.41 4.89 4.98
Stock Adjustments 36.90 45.30 -19.50 14.56 35.82 -1.67
Total Income 1,761.80 1,910.10 1,767.60 2,043.00 1,983.43 1,723.75
EXPENDITURE :            
Raw Materials 798.60 882.60 805.20 1,121.59 1,032.21 906.71
Power and Fuel Cost 169.80 168.10 170.20 186.91 175.46 147.83
Employee Cost 266.00 242.30 244.00 220.40 201.35 164.32
Other Manufacturing Expenses 132.40 141.50 136.50 114.60 106.37 91.27
Selling and Administration Expenses 130.00 115.20 116.20 110.01 101.31 64.05
Miscellaneous Expenses 117.30 26.90 26.10 27.02 21.28 21.71
Employee Benefit Expenses 266.00 242.30 244.00 220.40 201.35 164.32
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,614.10 1,576.60 1,498.20 1,780.53 1,637.98 1,395.88
Operating Profit 147.70 333.50 269.40 262.47 345.46 327.87
Interest 62.10 75.20 56.40 48.10 31.22 36.20
Gross Profit 85.60 258.30 213.00 214.37 314.24 291.67
Depreciation 163.80 134.40 117.60 109.01 95.67 85.25
Profit Before Tax -78.20 123.90 95.40 105.36 218.57 206.42
Current Tax -2.00 30.00 28.40 30.48 59.65 79.55
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -27.50 3.00 -2.50 -3.49 -1.59 -6.27
Reported Net Profit -48.70 90.90 69.50 78.38 160.51 133.14
Extraordinary Items -76.00 0.63 0.42 0.45 0.14 0.01
Adjusted Net Profit 27.30 90.27 69.08 77.93 160.37 133.13
Adjustment below Net Profit -2.20 -1.40 -0.70 -0.60 1.19 -1.44
P & L Balance brought forward 998.60 924.00 870.00 804.60 670.03 553.12
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.30 14.90 14.80 12.33 27.13 14.80
P & L Balance carried down 935.40 998.60 924.00 870.05 804.60 670.03
Dividend 2.40 0.00 0.00 0.00 0.00 12.33
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 70.00 60.00 60.00 80.00 100.00
Dividend Per Share(Rs) 0.60 1.40 1.20 1.20 1.60 2.00
Earnings Per Share-Unit Curr -3.94 7.36 5.63 6.36 13.02 10.80
Earnings Per Share(Adj)-Unit Curr -3.94 7.36 5.63 6.36 13.02 10.80
Book Value 97.09 102.20 96.16 91.93 86.62 75.70
Book Value(Adj)-Unit Curr 97.09 102.20 96.16 91.93 86.62 75.70

Shareholding Pattern

  • Promoter Group

    68.85%

  • Public Share Holding

    31.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 72,172,664 58.53 72,172,664 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,082,600 9.80 12,082,600 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 637,500 0.52 637,500 7
Others 0 0.00 0 0
Sub Total 84,892,764 68.85 84,892,764 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 250 0.00 250 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,218,569 0.99 1,218,569 32
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 7,301,726 5.92 7,301,726 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,619,232 1.31 1,619,232 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,139,777 8.22 10,139,777 41
2] Non Institution
Bodies Corporate 1,551,327 1.26 1,551,327 262
Clearing Members 83,346 0.07 83,346 30
Directors of their Relatives 450,976 0.37 450,976 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,195,728 1.78 2,195,728 1,482
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,318,542 1.07 1,318,542 1,436
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,299,482 1.86 2,299,482 8
Individuals holding nominal share capital up to Rs. 1 lakh 19,693,725 15.97 19,584,450 70,196
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,515 0.02 18,515 2
Others 420,653 0.34 420,653 6
Sub Total 28,268,209 22.93 28,158,934 73,469
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 123,300,750 100.00 123,191,475 73,527

Company Background

Hikal LtdPharmaceuticals - Indian - Bulk Drugs

  • Hikal Ltd
  • BSE Code : 4401.0
  • ISIN : INE475B01022

  • Incorporation Year

    1988

  • Registered Office

    717/718 Maker Chamber V
    7th Floor Nariman Point, Mumbai,
    Maharashtra-400021

  • Telephone

    91-022-3926 7100/62770477

  • FAX

    91-022-2283 3913

  • Chairman

    J Hiremath

  • Managing Director

  • Company Secretary

    Rajasekhar Reddy

  • Auditor

    S R B C & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Hikal Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hikal 201.05 1,724.90 1,712.60 -73.92 3.35
Abbott India 26,025.15 7,217.19 6,929.05 34.25 43.78
Astrazeneca Phar 6,870.25 2,304.07 2,275.58 101.26 27.86
Glaxosmi. Pharma 2,946.60 3,932.76 3,790.20 47.07 58.17
Novartis India 1,602.15 398.23 356.27 40.46 16.64
Cipla 1,413.15 20,102.60 18,979.95 37.14 13.88
Bliss GVS Pharma 649.00 773.53 729.81 60.26 12.51
Fermenta Biotec. 522.75 474.15 450.25 24.40 18.77
Amrutanjan Healt 501.90 520.13 502.55 26.88 24.16
Guj. Themis Bio. 412.60 152.47 150.80 110.32 27.21
Ambalal Sarabhai 44.79 19.52 3.94 82.94 6.77